Retour aux projets

19085.1 PFLS-LS

Biosensors for patient self-monitoring in metabolic diseases

Résumé

Biosensors for patient self-monitoring in metabolic diseases

Textes supplémentaires

Abstract

Patients suffering from the metabolic disease Maple Syrup Urine Disease (MSUD) have to undergo regular blood tests in order to monitor their branched chain amino acid (Leu, Ile and Val) levels. Based on a conceptually new sensing mechanism, we will develop biosensors that will allow patients to do these tests themselves using a simple handheld device; similar to the way diabetics monitor their blood sugar levels.

Participants

Alberto Schena

Wirtschaftspartner

alberto.schena@lucentix.ch

Lucentix Alberto Schena Bâtiment C / EPFL Innovation Park 1015 Lausanne VD CH

Kai Johnsson

Kontaktperson

kai.johnsson@epfl.ch

EPFL SB ISIC LIP Kai Johnsson Bâtiment BCH 4303 1015 Lausanne VD CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-06-30
Date de fin
2017-07-31
Coûts totaux approuvés
CHF 105252.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T115 Medical technology 100.0%